Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
07/2008
07/24/2008WO2007112015A3 Phenolic hydrazone macrophage migration inhibitory factor inhibitors
07/24/2008US20080177060 Use of axial substituted phthalocyanine compoud for preparing organic thin-film transistor
07/24/2008US20080176877 platelet lowering agent anagrelide especially 3-and 5-substituted analogues, with reduced potential for cardiovascular side-effects; imidazo[2,1-b]quinazolin-2-one derivatives; by inhibiting megakaryocytopoeisis; antiproliferative agents
07/24/2008US20080176875 Substituted quinazolines
07/24/2008US20080176872 Chemical Compounds
07/24/2008US20080176870 Heterobicyclic metalloprotease inhibitors
07/24/2008US20080176869 e.g. N-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxamide; viricide in combination with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; AIDS
07/24/2008US20080176868 Preparation and use of compounds as protease inhibitors
07/24/2008US20080176844 Pharmacokinetically Improved Compounds
07/24/2008US20080176835 Prenyl Transferase Inhibitors
07/24/2008US20080176832 Pyrazolo [3,4-D]Azepine Derivatives as Histamine H3 Antagonists
07/24/2008US20080176747 3,4-diaminopyridine derivatives
07/24/2008US20080175914 Inflammatory and/or allergic diseases; cognitive impairment
07/24/2008US20080175796 Delivery of Drug Esters Through an Inhalation Route
07/24/2008CA2675676A1 Nicotinic acetylcholine receptor modulators
07/24/2008CA2674698A1 New classical antifolates
07/23/2008EP1947102A1 Compositions comprising diazepinoindole derivatives as kinase inhibitors
07/23/2008EP1945645A1 Crystalline forms of pemetrexed diacid and processes for the preparation thereof
07/23/2008EP1945644A2 Imidazopyrazines as protein kinase inhibitors
07/23/2008EP1945643A2 Imidazopyrazines as cyclin dependent kinase inhibitors
07/23/2008EP1945642A1 Pyrazolo-pyrimidine derivatives as anti-inflammatory agents
07/23/2008EP1945641A1 Hepatitis c virus inhibitors
07/23/2008EP1945220A1 Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists
07/23/2008EP1732933B1 Compounds for treating dyslipidemia
07/23/2008EP1080092B1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
07/23/2008CN101228171A Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
07/23/2008CN101228170A Fungicidal 5-alkyl-6-phenylpyrazolopyrimidin-7-ylamines
07/23/2008CN101228169A Macrocyclic inhibitors of hepatitis c virus
07/23/2008CN101228168A 6-phenyl-pyrazolopyrimidine-7-ylamine fungicides
07/23/2008CN101228167A Pyrazolo[1,5-a]pyrimidin-7-yl amine derivatives as protein kinase inhibitors
07/23/2008CN101228166A Fungicidal 6-phenyltriazolopyrimidinylamines
07/23/2008CN101228165A Fungicidal 5-methyl-6-phenylpyrazolopyrimidin-7-ylamines
07/23/2008CN101228164A Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
07/23/2008CN101228163A Aspartyl protease inhibitors
07/23/2008CN101228162A 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators
07/23/2008CN101228161A Pyrrolopyridines useful as inhibitors of protein kinase
07/23/2008CN101227819A Fungicide 5-methyl-6-phenyl-triazolopyrimidinyl amines
07/23/2008CN101225086A Method for synthesizing mu-oxo binuclear ferriporphyrin
07/23/2008CN100404538C Production method of chlorophyll cupric acid and its sodium salt
07/23/2008CN100404537C Quinazolin allkaloids compound, preparation method and use thereof
07/23/2008CN100404536C Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
07/23/2008CN100404535C Organic compounds as agents for the treatment of aldosterone mediated conditions
07/23/2008CN100404533C New quinuclidine amide derivatives
07/23/2008CN100403900C Mitotic kinesin inhibitors
07/22/2008US7402835 Heteroatom-containing diamondoid transistors
07/22/2008US7402682 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates
07/22/2008US7402680 Nervous system disorders; psychological disorders; sleep disorders; anxiolytic agents; schizophrenia; analgesics; eating disorders
07/22/2008US7402639 Narrow moleculae weight distribution; addition piolymers; process control
07/22/2008US7402582 such as 2-(2-{[6-({3-[4-(hydroxymethyl)piperidin-1-yl]propyl}oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino}-1,3-thiazol-5-yl)-N-(3-methylphenyl)acetamide; serine/threonine Aurora kinase inhibitor; anticarcinogenic agent;
07/22/2008US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants
07/22/2008CA2388076C Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
07/22/2008CA2368614C Improved cancer treatment with temozolomide
07/22/2008CA2265095C Pyrazolopyrimidines and pyrazolotriazines
07/17/2008WO2008086404A1 5-pyridinone substituted indazoles
07/17/2008WO2008086264A1 Intermediates useful in preparing certain pyrrolotriazine compounds and a process for making the intermediates
07/17/2008WO2008086128A2 Aminopyrazole kinase inhibitors
07/17/2008WO2008085216A1 Therapeutic hpph dosage for pdt
07/17/2008WO2008084872A1 Hydrazone derivative
07/17/2008WO2008084082A1 Method for production of aryl-substituted annelated pyrimidines
07/17/2008WO2008084027A1 Use of azolopyrimidines for fighting plant pathogenic fungi
07/17/2008WO2008083975A1 Light-stabilized composition
07/17/2008WO2008083729A1 Radiolabelling via fluorination of aziridines
07/17/2008US20080171733 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine
07/17/2008US20080171657 5,6-Dialkyl-7-Aminoazolopyrimidines, Their Preparation and Their Use for Controlling Harmful Fungi, and Compositions Comprising These Compounds
07/17/2008US20080171403 Irradiating porphyrins, azaporphyrins; improved crystal structure and orientation; field effect transistors
07/17/2008US20080171015 Compounds for the Treatment of Hepatitis C
07/17/2008CA2674408A1 Radiolabelling via fluorination of aziridines
07/17/2008CA2673654A1 5-pyridinone substituted indazoles
07/16/2008EP1944306A1 Fused heterocyclic compounds as serotonin receptor modulators
07/16/2008EP1944288A1 Radiolabelling via fluorination of aziridines
07/16/2008EP1943505A1 Novel electropolymerisable monomers which are soluble in an aqueous solution and comprise a metalloporphyrine
07/16/2008EP1943252A2 Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid
07/16/2008EP1943217A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
07/16/2008EP1943216A1 Prolinamide derivatives as sodium channel modulators
07/16/2008EP1942900A2 Use of pyrazolo [1,5-a] pyrimidine derivatives for inhibiting kinases methods for inhibiting protein kinases
07/16/2008EP1765826B1 Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles
07/16/2008EP1641801B1 Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
07/16/2008EP1608655B1 Pyrroloimidazole derivatives, their preparation, pharmaceutical compositions containing them, and their use as nootropic agents
07/16/2008EP1590343B1 Synthesis of 2-butyl-3-(2' -(1-trityl-1h-tetrazol-5-yl)biphen yl-4-yl)-1,3-diazaspiro-4,4 -nonene-4-one
07/16/2008EP1517890B1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof
07/16/2008EP1476151B1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
07/16/2008EP1466527B1 Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method of controlling weed with the same
07/16/2008EP1392264B1 Delivery of antiemetics through an inhalation route
07/16/2008EP1392257B1 Delivery of antihistamines through an inhalation route
07/16/2008CN101223174A New derivatives of heptaazaphenalene, methods for obtaining them, and their use as protecting agents against UV radiation
07/16/2008CN101223173A 5-alkyl-7-amino-6-heteroaryl-1,2,4-triazolo[1,5-a]pyrimidine compounds and use thereof for the prevention of fungal pests
07/16/2008CN101223172A Substituted rylene derivatives
07/16/2008CN101223171A Pharmacokinetically improved compounds
07/16/2008CN101223167A Novel heteroaryl fused cyclic amines
07/16/2008CN101223141A Certain substituted amides, method of making, and method of use thereof
07/16/2008CN101220034A Inverse V type ultra-gees alkali derivant electroluminescent organic material
07/16/2008CN101220033A Synthesis of temozolomide and analogs
07/16/2008CN101220027A Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands
07/16/2008CN101220026A 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
07/16/2008CN100402530C Pyrimidotriazines as phosphatase inhibitors
07/16/2008CN100402515C Substituted phthalides as anti-convulsive drugs
07/16/2008CN100402499C 2-iminopyrrolidine derivatives
07/15/2008US7399868 4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
07/15/2008US7399765 Substituted diazabicycloalkane derivatives
07/15/2008US7399764 N-ethyl-N'-{(3R)-1-[4-(3-phenylthieno[3,4-b]pyrazin-2-yl)benzyl]pyrrolidin-3-yl}urea; inhibit activity of a serine, threonine protein kinase; cancer